Broker recommendations for Takeda Pharmaceutical Co., Ltd
The Takeda Pharmaceutical Co., Ltd stock is rated at 1.230769 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Friday 25 September, 2020 by a total of 13 brokers. This means that the consensus of the 13 different brokers is leaning toward to buy/moderate buy.
Sell
0 (0%) Underweight
0 (0%) Hold
2 (15.38%) Overweight
2 (15.38%) Buy
9 (69.23%)
Price target by analysts
The 12 latest analyst estimates, per Saturday 17 October, 2020, show the following high, low and average price targets.
Target Average: 25.1 USD
Target High: 30.63 USD
Target Low: 19.37 USD
Sleeping Medications Market COVID-19 Impact, Global Analysis and Forecast to 2027| Pfizer, Sanofi, Sumitomo Dainippon Pharma Co., Takeda Pharmaceutical Company Ltd., Teva Pharmaceutical Industries Ltd.
Thursday, 15 October 2020, 20:29:28
Sleeping medications are known as sleeping pills. Sleeping pills mainly refers to a generic term that is used for describing both over-the-counter (OTC) or prescription medications. Sleeping pills are majorly used for helping individuals who face difficulty in falling asleep
— OpenPR
Japan stocks fall as risks on several fronts unsettle investors
Thursday, 15 October 2020, 10:29:41
The biggest underperformers among the top 30 core Topix names were venture capitalist SoftBank Group Corp, down 2.08%, followed by drugs maker Takeda Pharmaceutical Co Ltd losing 1.97%.
— Economic Times India
Next Generation Bio-therapeutics Market Insights 2020: Business Analysis By 2026 With Leading Players Takeda Pharmaceutical Company Limited, AstraZeneca, F. Hoffmann-La Roche Ltd
Tuesday, 13 October 2020, 20:45:40
Data Bridge Market Research recently introduced Global Next Generation Bio-therapeutics Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2026. The market Study is segmented by key regions which is accelerating
— OpenPR
Non-Small Cell Lung Cancer Market (COVID – 19 Updates) 2020 to See Stunning Growth Worldwide, Leading Players -Takeda Pharmaceutical Company Limited (Japan), Ono Pharmaceutical Co., Ltd. (Japan), F. Hoffmann-La Roche Ltd (Switzerland)
Tuesday, 13 October 2020, 20:41:02
Data Bridge Market Research has recently added a concise research on the Global Non-Small Cell Lung Cancer Market – Industry Trends and Forecast to 2026. Global Non-Small Cell Lung Cancer Market research report has been prepared with a nice combination
— OpenPR
Takeda Pharmaceutical : Accelerates Digital Transformation with Accenture and AWS | MarketScreener
Tuesday, 13 October 2020, 13:03:01
Collaboration will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs and develop the workforce of the future … | October 13, 2020
— MarketScreener
We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.
